An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3
Clinical Trials Related to Xenon Pharmaceuticals Inc.
Related studies linked through entity extraction aliases.
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
- Status
- RECRUITING
- Phase
- PHASE3
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Status
- RECRUITING
- Phase
- PHASE3
An Open-Label Study of Azetukalner in Major Depressive Disorder
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Status
- RECRUITING
- Phase
- PHASE3
An Open-label Study of XEN1101 in Epilepsy
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Status
- RECRUITING
- Phase
- PHASE3
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 in Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE2
Single-dose Mass Balance Recovery and Metabolite Profile and Identification of 14C-XEN1101
- Status
- COMPLETED
- Phase
- PHASE1
An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEE
- Status
- TERMINATED
- Phase
- PHASE3
XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy
- Status
- TERMINATED
- Phase
- PHASE3
A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety, Tolerability, Pharmacokinetics and Effects on Transcranial Magnetic Stimulation of Oral Doses of XEN1101
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of XEN901
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of XEN1101.
- Status
- COMPLETED
- Phase
- PHASE1
A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 2a, Exploratory Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of XPF-002 in Patients With Primary/Inherited Erythromelalgia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Crossover Study to Evaluate the Safety, Tolerability and Efficacy of XPF-002 in Subjects With Postherpetic Neuralgia (PHN)
- Status
- COMPLETED
- Phase
- PHASE2